Zobrazeno 1 - 10
of 11
pro vyhledávání: '"L. Petrariu"'
Publikováno v:
Romanian Journal of Rheumatology, Vol 26, Iss 3, Pp 129-134 (2017)
Although antibodies targeting Ro52 protein/TRIM21 are commonly detected in systemic autoimmune rheumatic disorders (SARDs), their clinical significance and pathobiologic role remains incompletely understood. Objectives. We aimed to define clinical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3bb440ffd6f75c2222b5dfd952be39b
https://doi.org/10.37897/rjr.2017.3.4
https://doi.org/10.37897/rjr.2017.3.4
Autor:
G. Strugariu, Codruta Bran, R. Paiu, E. Ancuta, Ancuta Codrina, L. Petrariu, Cristina Pomirleanu, Rodica Chirieac
Publikováno v:
Poster Presentations.
Background The risk of tuberculosis (TB), either reactivation of latent TB or de novo infection, remains a point of interest in patients with immune-mediated rheumatic pathology on biological therapy, particularly TNFα inhibitors. Objectives We aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea8a702847f02e989e873acbfe46f1dc
https://doi.org/10.1136/annrheumdis-2019-eular.3657
https://doi.org/10.1136/annrheumdis-2019-eular.3657
Autor:
Ancuta Codrina, E. Ancuta, Claudia Mihailov, L. Petrariu, Cristina Pomirleanu, Codruta Bran, R. Paiu, G. Strugariu, Rodica Chirieac
Publikováno v:
Spondyloarthritis – treatment.
Background Although the efficacy and long-term persistence of TNF inhibitors (TNF-i) are widely recognized in axial spondyloarthritis (axSpA), up to about one third of patients experience failure (loss of therapeutic response or toxicity) with the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501dbb5575b711762c2ac10f38196b9d
https://doi.org/10.1136/annrheumdis-2019-eular.4272
https://doi.org/10.1136/annrheumdis-2019-eular.4272
Autor:
G. Strugariu, Cristina Pomirleanu, Codrina Ancuta, E. Ancuta, L. Petrariu, Claudia Mihailov, Rodica Chirieac, Codruța Bran
Publikováno v:
Annals of the Rheumatic Diseases. 80:1380.2-1381
Background:Despite emerging vaccines, the world is in the midst of a coronavirus disease 2019 (COVID-19) pandemic. Outcomes of SARS-CoV2 infection remain a major concern in patients with rheumatic and musculoskeletal diseases, especially for those wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59039786d51c9479179b2b8a5ea79bff
https://doi.org/10.1136/annrheumdis-2021-eular.3467
https://doi.org/10.1136/annrheumdis-2021-eular.3467
Autor:
Codrina Ancuta, Cristina Pomirleanu, R. Paiu, Codruța Bran, L. Petrariu, E. Ancuta, G. Strugariu, Rodica Chirieac
Publikováno v:
Saturday, 16 JUNE 2018.
Background Although widely recognised as extra-articular manifestations of axial spondyloarthritis (axSpA), uveitis developing throughout anti-TNFα treatment is difficult to be classified as disease related or paradoxical event. Objectives We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e478c2901a0517a4e219110eb5a74297
https://doi.org/10.1136/annrheumdis-2018-eular.4071
https://doi.org/10.1136/annrheumdis-2018-eular.4071
Autor:
R. Paiu, G. Strugariu, Rodica Chirieac, Cristina Pomirleanu, C. Iordache, E. Ancuta, C. Ancuta, L. Petrariu
Publikováno v:
Saturday, 16 JUNE 2018.
Objectives We aimed to evaluate the immunogenicity of TNF-α inhibitors and to assess potential influence on serum drug levels and clinical efficacy in patients with axial spondyloarthritis (axSpA). Methods We performed a cross sectional observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f21ec6f3aae1f728e0d6ad2fae975a7
https://doi.org/10.1136/annrheumdis-2018-eular.2979
https://doi.org/10.1136/annrheumdis-2018-eular.2979
Autor:
Rodica Chirieac, G. Strugariu, R. Paiu, Codrina Ancuta, L. Petrariu, E. Ancuta, Cristina Pomirleanu, A. Chiriac
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background Defined as de novo or exacerbation of pathologies that usually responds to biologic agents, paradoxical reactions encompass for a wide spectrum of manifestations (cutaneous, intestinal, ocular) reported during biological therapy (TNF and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e16f72b77ed0f3b9d630447a2f0c2b80
https://doi.org/10.1136/annrheumdis-2018-eular.4854
https://doi.org/10.1136/annrheumdis-2018-eular.4854
Autor:
E. Ancuta, R. Maxim, Rodica Chirieac, Cristina Pomirleanu, L. Petrariu, Codrina Ancuta, G. Strugariu
Publikováno v:
Poster Presentations.
Background The risk of infections, especially severe infections (SI), remains of particular interest in rheumatoid arthritis (RA), both defective immune response and therapeutic immunosuppression being responsible. The RABBIT Risk Score (RRS), an ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28d4572ea17fe76e855faca2ee2fb3dd
https://doi.org/10.1136/annrheumdis-2017-eular.2774
https://doi.org/10.1136/annrheumdis-2017-eular.2774
Autor:
E. Ancuta, Codrina Ancuta, L. Petrariu, C. Belibou, Cristina Pomirleanu, Rodica Chirieac, I. Esanu, G. Strugariu, R. Maxim
Publikováno v:
Annals of the Rheumatic Diseases. 75:807.2-807
Background Up to one third of spondylarthritis (SpA) fail to respond to anti-TNF agents or experience drug toxicity leading to treatment withdrawal. Part of the treatment failure can be explained by the development of anti-drug antibodies (ADA). Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ef1e1dc1b1959a0ee259e646d5318f
https://doi.org/10.1136/annrheumdis-2016-eular.4271
https://doi.org/10.1136/annrheumdis-2016-eular.4271
Publikováno v:
Annals of the Rheumatic Diseases. 75:613.2-613
Background The autoimmune myopathies (IM) comprise a broad spectrum of acquired muscular disorders characterized by autoimmune damage of skeletal muscle and complex visceral involvement, leading to chronic dysfunction and disability. Objectives The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5c6532094aef82821044d8b0ffa9d34
https://doi.org/10.1136/annrheumdis-2016-eular.4543
https://doi.org/10.1136/annrheumdis-2016-eular.4543